The penicillins, cephalosporins, carbapenems, and monobactams, make up the β‐lactam family of antibiotics. There are currently more than 25 antibiotics in this family that are approved by the United States Food and Drug Administration and over 50 companies that manufacture them. Their four‐membered β‐lactam ring, which is the part of the antibiotic that is responsible for their bactericidal capabilities, is sensitive to acids, bases, and heat. Therefore, the original chemical synthesis processes utilized to make these compounds required subzero temperatures, hazardous chemicals for protecting groups, and large volumes of organic solvents, rendering them both environmentally harmful and economically taxing. The original syntheses are increasingly being replaced with biocatalytic syntheses which are carried out at ambient temperatures, in aqueous medium, and without the use of auxiliary chemicals, rendering them environmentally benign and economically advantageous processes. The most important enzymes utilized for these processes are penicillin G acylases, penicillin V acylases, cephalosporin acylases, and expandases.